publication date: Feb. 27, 2015

ORIEN Big Data Collaboration Adds Four Cancer Centers

 

The Oncology Research Information Exchange Network, a precision cancer research collaboration founded by Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center, announced the addition of four cancer centers Feb. 23, bringing its membership to six.

The new members of ORIEN include City of Hope, University of Virginia Cancer Center, University of Colorado Cancer Center, and the University of New Mexico Cancer Center.

The addition of the new ORIEN members is expected to exponentially increase the number of patients consenting to donate their tissue and clinical data—including corresponding genomic data—for research to understand cancer at the molecular level, with the goal of developing more targeted cancer treatments.

Additional nationally designated cancer centers are in the process of joining ORIEN, where partners share de-identified data to accelerate the development of targeted treatments, allowing researchers and clinicians to more quickly match eligible patients to clinical trials and conduct larger and richer analyses.

According to a statement from Ohio State, ORIEN personifies “big data”—extensive databases with cancer patient information (medical history, cancer tissue, and DNA) that can be used for basic research and clinical trials—that puts cancer genomics on the leading edge of precision medicine.

ORIEN is expanding just as the national spotlight is focused on the promise of precision medicine. President Barack Obama revealed his plans to invest in precision medicine during his State of the Union address, and on Jan. 30 unveiled the $215 million initiative.

“The growth of ORIEN coincides with President Obama’s announcement and the recognition that molecularly targeted medicine holds tremendous promise for all disease, particularly cancer,” said Michael Caligiuri, director … Continue reading 41-08 ORIEN Big Data Collaboration Adds Four Cancer Centers

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.